In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
暂无分享,去创建一个
Dong Chen | Linlin Li | Tianlong Liu | Nanjing Hao | Linlin Li | Fangqiong Tang | Huiyu Liu | Tianlong Liu | Nanjing Hao | Dong Chen | Xu Teng | Junqi He | Fangqiong Tang | Huiyu Liu | Xu Teng | Junqi He
[1] Linlin Li,et al. Facile and Scalable Synthesis of Tailored Silica “Nanorattle” Structures , 2009 .
[2] L. Archer,et al. Hollow Micro‐/Nanostructures: Synthesis and Applications , 2008 .
[3] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] V. S. Lin,et al. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.
[5] Michael J Sailor,et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.
[6] Brian G. Trewyn,et al. Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications , 2007 .
[7] P. Vrignaud,et al. Preclinical evaluation of docetaxel (Taxotere). , 1995, Seminars in oncology.
[8] Robert J. Gillies,et al. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells , 2005, Molecular Cancer Therapeutics.
[9] Yufang Zhu,et al. Rattle-type Fe(3)O(4)@SiO(2) hollow mesoporous spheres as carriers for drug delivery. , 2010, Small.
[10] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[11] Zongxi Li,et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.
[12] Masahiro Fujiwara,et al. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica , 2003, Nature.
[13] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[14] Victor S-Y Lin,et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. , 2003, Journal of the American Chemical Society.
[15] M. Vallet‐Regí,et al. A New Property of MCM-41: Drug Delivery System , 2001 .
[16] L. Milas,et al. Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel , 1999, Cancer Chemotherapy and Pharmacology.
[17] J. M. Harris,et al. Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.
[18] Sanjiv S Gambhir,et al. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.
[19] Yoo-Hun Suh,et al. Porous, Hollow, and Ball‐in‐Ball Metal Oxide Microspheres: Preparation, Endocytosis, and Cytotoxicity , 2006 .
[20] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.
[21] Saji George,et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.
[22] Min Zhang,et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.
[23] Longgui Wang,et al. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review , 1999, Cancer Chemotherapy and Pharmacology.
[24] G. Hortobagyi,et al. Docetaxel for treatment of solid tumours: a systematic review of clinical data. , 2005, The Lancet. Oncology.
[25] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[26] Taeghwan Hyeon,et al. Designed Fabrication of Silica‐Based Nanostructured Particle Systems for Nanomedicine Applications , 2008 .
[27] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[28] Hamidreza Ghandehari,et al. Cellular uptake and cytotoxicity of silica nanotubes. , 2008, Nano letters.
[29] Arun K Iyer,et al. Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma , 2009, BMC Cancer.
[30] Weibo Cai,et al. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.
[31] Feng Chen,et al. Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. , 2010, ACS nano.
[32] F. Caponigro,et al. Docetaxel in the management of head and neck cancer , 2009, Anti-cancer drugs.
[33] Kazunori Kataoka,et al. PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .
[34] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[35] J. Eriksson,et al. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems. , 2009, Nano letters.
[36] Monty Liong,et al. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. , 2007, Small.
[37] Victor S-Y Lin,et al. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.
[38] L. Cattel,et al. Clinical and pharmacokinetic data of a docetaxel-epirubicin combination in metastatic breast cancer , 2001, Breast Cancer Research and Treatment.
[39] Rasmus Niemi,et al. Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.